Granules India Limited is a fully integrated pharmaceutical manufacturer, specializing in the production of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The company, founded in 1984, operates within the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries and is headquartered in India. With a global presence, its products are distributed in over 55 countries. In their most recent funding round, Granules India Limited received a Post-IPO Equity investment on 01 September 2005 from MAPE Advisory Group. This investment has enabled the company to further strengthen its position in the pharmaceutical market and expand its reach internationally. Granules India's comprehensive product offerings and widespread distribution demonstrate its potential for continued growth and impact in the pharmaceutical industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | Unknown | 1 |
|
01 Sep 2005 |
No recent news or press coverage available for Granules India Limited.
We care about your data, and we'd love to use cookies make your experience better.
